As expected, continued low volume. Still trying to pick up the last small tranche for my IRA. MMPJoe could knock our sox off Monday, but no reason to overpay. I think he has an excellent handle on maintaining interest in a small (for now) biotech. The old regime did a great job of teaching what not to do. Steady low volatility and volume into uplisting is ok with me. Uplisting is the total game-changer. I don’t think the Naz would allow a weak, flawed company to return to its board. It’s Donohoe’s job to insure that doesn’t happen. Regarding Monday, you never know who is going to attend and respond to MMPJoe’s charm.